Targeted Nanostructured Lipid Carrier-Mediated Flavonoid Delivery for Enhanced Therapeutic Efficacy in Non-Small Cell Lung Cancer (NSCLC). APIMR [Internet]. 2026 Jun. 10 [cited 2026 Jul. 16];1(1):73-97. Available from: https://apimr.nknpub.com/1/article/view/4